Oramed Receives European Patent for Oral Delivery of Insulin


Oramed is an Israel company that is doing clinical trials for orally delivered insulin. This is a holy grail for diabetes sufferers who currently have to have regular injections which is unpleasant and can cause infection. For hemophiliacs with diabetes, injections are obviously particularly problematic.

Oramed has now received a European patent for their invention. See here. The patent in question was drafted by Dr Moshe Tritel who unfortunately for me, stayed with JMB, Davis Ben-David, when JMB Factor & Co. disbanded a couple of years ago. Oramed, of course, stayed with Dr Tritel.

Testing for insulin still requires pricking one’s thumb and extracting a drop of blood. One of my Israel clients, AD Integrity, has developed a non-invasive way of monitoring glucose content in blood.

These Israeli inventions are set to revolutionize the lives of the growing number of diabetes sufferers.

Categories: drugs, EPO, Intellectual Property, Israel, Israel IP, Israel Patent, Israel Related, Patents, pharmaceuticals, pharmaceuticals and Biotechnology

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: